Unpacking Obama's Global Health Initiative

In the dense world of bureaucratic strategy and technical policy briefs, it's easy to get lost in alphabet soup and technical jargon. The Obama administration's Global Health Initiative — announced last spring — may be a critical step for U.S. foreign policy, but what does the six-year, $63 billion initiative really mean?

To understand what the White House is proposing, here's a quick primer to help you understand three of the initiative's top-used terms:

1). Country ownership: The GHI has made a point of increasing "country ownership" in the use and delivery of funding for health. The goal of giving governments more control over their programming is a praiseworthy one. Unfortunately, when it comes to eight of the countries recently selected for inclusion in the GHI (including Nepal, Malawi, Ethiopia and Guatemala), U.S. officials seem to be moving in another direction, arguing that such countries would benefit from more "management and technical support rather than funds."

Do countries really need more U.S. advisors to enhance their feeling of "ownership"? Seems like a dubious at best. As Mead Over writes, what countries really need is simple — budget support.

What's more, calls for country ownership don't jive with the fact that the Obama administration has broken its pledge to back the Global Fund for HIV/AIDS, Tuberculosis and Malaria, which supports countries in developing their own funding proposals (in contrast to such U.S. efforts overseas, which tend to promote U.S.-based organizations' work).

2). Integration: Instead of "stove-piped" programs, or highly focused programs targeting diseases like AIDS or malaria, the GHI aims to encourage "integrated" services for a broad array of diseases and conditions. How will this affect health centers? Can this kind of "integration" create savings and a higher quality and array of services for patients? These questions remain to be answered.

3). Cost-effectiveness: The use of cost-effectiveness analyses — comparing the relative costs and benefits of different interventions — isn't new in public health. But given the global recession and increasing budget pressures, cost-effectiveness analyses have become even more dominant in calculations over how to spend money. Dr. Ezekiel Emanuel — the White House Chief of Staff's brother, and one of architects of the GHI — has even declared that it's an "ethical imperative" to spend money on the cheapest interventions, such as certain neglected tropical diseases. But does a "cost-effective" strategy hold up to scientific or moral scrutiny? For example, HIV/AIDS treatment is increasingly under attack for not being "cost-effective." But by denying care to millions of AIDS patients, many related health goals (such as maternal and child health) set by the GHI cannot be reached. Pitting diseases vs. diseases in the battle for funding doesn't seem like the best way forward for global health.

All of these terms are gateways into fascinating — and controversial — debates. As more policy documents and arguments about the U.S. direction on global health emerge, it's important to pay close attention to what these terms really mean.

Photo Credit: horia varlan